Genitourinary Treatments & Services

Moffitt Cancer Center's Genitourinary Oncology Program consists of a multidisciplinary team that is at the forefront of research and treatment of urologic cancers, such as bladder, kidney, prostate, testis and penile cancer. As a referring physician, your patients will have access to the full spectrum of specialized care at Moffitt. 

Click on the plus signs to read more about our services and treatments.

• Multidisciplinary program services
  • Medical oncology
  • Nutrition consults
  • Nuclear medicine
  • Pathology
  • Infusion
  • Radiation oncology
  • Radiology readings from genitourinary specialists
  • Evaluation, diagnosis and staging
    • PET (positron emission tomography) and MRI (magnetic resonance) scans
    • High-resolution CT (computed tomography) scans
    • CT or MRI urogram
    • Transrectal ultrasound
    • Endoscopic ultrasound
    • Contrast-enhanced ultrasound
    • EUS-guided biopsy
  • Supportive care
  • Surgical oncology
  • Urologic oncology
  • Personalized medicine
  • Genetic Counseling
  • Survivorship services
  • Access to active clinical trials and advanced treatment protocols
• Evidence-driven treatment options

  Moffitt offers a diverse range of treatments to patients with all types of urologic cancers. These include:

  • Active surveillance for prostate conditions
  • Chemoprevention
  • Chemotherapy
    • Molecular targeted therapeutics
    • Neoadjuvant chemotherapy protocols
  • Immunotherapy
  • Innovative therapies
    • Gene therapies
    • Hormone therapies
    • Vaccine therapies
  • Focal therapies
  • Radiation therapy
    • Interventional Radiology
      • Prostatic Artery Embolization
    • Conformal radiotherapy
    • HDR brachytherapy (seeds)
    • Stereotactic radiosurgery (SRS)
    • Stereotactic body radiotherapy (SBRT)
      • MR-guided radiotherapy
      • CT-guided radiotherapy
    • Intensity modulated radiation therapy (IMRT)
  • Surgery
    • Inguinal, pelvic and retroperitoneal lymph node dissection
    • Minimally invasive surgical approaches
      • Laser surgery
      • Laparoscopic and robotic surgery
    • da Vinci® robotic surgery for cancers of the bladder, kidney, testis, adrenal and prostate
    • Partial and radical nephrectomy
    • Prostatectomy (nerve-sparing techniques)
    • Partial and radical orchiectomy
    • Partial and total penectomy
    • Radical cystectomy and various forms of urinary diversion (orthotopic, continent cutaneous, ileal conduit)
    • Organ- and sexual function-preserving surgical approaches
    • Retroperitoneal lymph node dissection (RPLND)
    • Inguinal lymph node dissection (ILND)

From #ASCO25: Roger Li, MD (@UrogerliMD), shares insights on the latest bladder cancer research presented at @ASCO and its potential impact on patient care. #MoffittASCO25 pic.twitter.com/z2YoNCPzYM

— Moffitt Cancer Center (@MoffittNews) June 2, 2025

Clinical Trials

Moffitt Cancer Center's Genitourinary Oncology Program offers one of the most comprehensive clinical trial portfolios for urinary cancers in Florida.

Patients referred here may gain access to:

• Investigator-Initiated Trials (IITs) led by Moffitt experts
• RO1 Grant-funded studies recognized nationally
• Exclusive trials available only at Moffitt

Why Refer Early

Eligibility for many trials can be limited once surgery has been performed. Referring patients early in their cancer journey, before surgical treatment, ensures they have the best chance to participate in groundbreaking studies.

Advancing Care

Clinical trials drive progress in prevention, diagnosis, and treatment. Most of today’s effective therapies for urinary cancers began as clinical trials. By referring your patients to Moffitt, you connect them to tomorrow’s innovations today.

View Clinical Trials

Refer a patient 

Referring a patient to Moffitt’s Genitourinary Oncology Program is simple—contact a physician liaison for assistance or submit an online form. We understand that a timely response is critical when it comes to cancer treatment, which is why our team strives to answer all referral requests within 24-48 hours.